Which of the following test is specific diagnostic test for disseminated intravascular coagulation (DIC)?

NORCERT 8 Mains-2025

Medical Surgical Nursing

Medium

Appeared in: NORCERT 8 Mains-2025

Explanation

D-Dimer is a specific type of fibrin degradation product (FDP).
It is formed only when cross-linked fibrin clots (stable clots) are broken down by the enzyme plasmin.
An elevated D-Dimer level is a hallmark of DIC because it confirms that both widespread coagulation (clot formation) and subsequent fibrinolysis (clot breakdown) are occurring simultaneously.
While sensitive, it's the most specific marker for DIC among the choices provided when interpreted in the correct clinical context.

Option A: PT (Prothrombin Time) measures the time it takes for a clot to form via the extrinsic pathway. While it is prolonged in DIC due to the consumption of clotting factors, it is not specific. Many other conditions can also prolong PT.
Option B: INR (International Normalized Ratio) is a standardized calculation derived from the PT result. Like PT, it is prolonged but not specific to DIC.
Option D: Bleeding time assesses platelet function, and clotting time is a general measure of the intrinsic pathway. Both are non-specific, outdated for diagnosing complex disorders like DIC, and have been replaced by more precise tests.

Visual 1: Flowchart - Illustrating the pathophysiology of DIC. The chart can show triggers (like sepsis or trauma) leading to systemic activation of coagulation, which causes fibrin deposition and consumption of clotting factors. This is followed by secondary fibrinolysis, resulting in the production of FDPs and D-dimers, leading to bleeding.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Specific laboratory diagnosis of Disseminated Intravascular Coagulation (DIC) as background academic context rather than a clinical decision trigger.
Nurses must be vigilant in monitoring patients at risk for DIC (e.g., those with severe sepsis, major trauma, or certain cancers) for signs of both clotting (e.g., cyanosis, organ failure) and bleeding (e.g., petechiae, oozing from IV sites).
Prompt recognition and reporting of abnormal lab values—specifically a rising D-dimer, falling platelet count, and prolonged PT/INR—are critical for early diagnosis and management of DIC.
What if? If a patient has an elevated D-dimer but a normal platelet count and PT/INR, the diagnosis is less likely to be DIC. Instead, a localized thrombotic event, such as a deep vein thrombosis (DVT) or pulmonary embolism (PE), should be suspected, as these conditions also raise D-dimer levels without the systemic consumption of clotting factors seen in DIC.

How to Approach the Question

First, identify the keywords in the question: 'specific diagnostic test' and 'disseminated intravascular coagulation (DIC)'. The word 'specific' is crucial.
Recall the basic pathophysiology of DIC: it is a dual process involving widespread, uncontrolled clotting followed by the breakdown of those clots (fibrinolysis).
Evaluate each option to see which one best reflects this unique dual process.
Consider PT and INR. These tests measure clotting time but are affected by many conditions, so they are not specific.
Consider Bleeding/Clotting time. These are general, less precise tests and not specific for DIC.
Consider D-Dimer. Recall that D-Dimer is a product formed only from the breakdown of a stable fibrin clot. Its presence confirms that both clotting and clot breakdown have occurred, making it the most specific marker for DIC among the choices.

Concept Tested & Keywords

Concept Tested: Specific laboratory diagnosis of Disseminated Intravascular Coagulation (DIC)
Stem keywords: specific diagnostic test, disseminated intravascular coagulation, DIC
Lead-in keywords: Which
Negative lead-in flag: false

Q_iPWqTzOfrW57vYUB1TaZ